FDA Okays Dexcom G5 Mobile Continuous Glucose Monitoring System

(RTTNews) - Medical device company Dexcom Inc (DXCM) on Tuesday said the U.S. Food and Drug Administration has approved the Dexcom G5 Mobile Continuous Glucose Monitoring ("CGM") System.

With wireless Bluetooth technology built into the device transmitter, the G5 Mobile CGM System is the first and only fully mobile CGM system approved by the FDA for both adults and children as young as 2 years of age that sends glucose data directly to a smartphone, freeing users from the need to carry a separate receiver.

The G5 Mobile system is anticipated to begin shipping in late September 2015.

All purchasers of a G4 Platinum with Share system from August 1, 2015, until the G5 Mobile system is shipped, will be eligible to receive a no-cost upgrade to the G5 Mobile system. There will be a low cost cash upgrade to the G5 Mobile system for those patients who are still under warranty with their existing system.